Lacey

Anonymous

Guest
Lets take the best SVP at Amgen and pacakge him out. SH or PE would have been a value added removal. Hmmm guy who built Amgen's pipeline versus guys who bring them down...
 












Agreed. This is Amgen's version of reverse-loyalty. Who is loyal to DL? ASF, and much of ATO. Who does Amgen want out of the way before the upcoming merger, buyout, RIF-downsize, whatever-business-strategy-will-fill-greedy-pockets-of-competitive-salary-execs-and-board-plus? The same: ASF, and much of research discovery. Why? To reduce costs and make Amgen look more attractive, e,g. fewer RIF-related costs. (Notice, DL is still going to pursue his own research interests, not Amgen's!) Is this Icahn's "external pressure" which is causing "new information" for KS' "yellow-status" rationale for a "pause"? Whatever; Amgen's board wants you to quit.